The ability of mRNA vaccines to be updated quickly offers a significant advantage in responding to new variants, ensuring that the public receives the most ... Jun 17
Latest Corporate News; Pharma Jan1st/2022... Feb 01
Latest pharma news update... Dec 30
WHO covid vaccine forecast... Sep 13
Zydus Cadila vaccine to be available by September... Jun 26
Covid Vaccines and their side effects... May 13
... Apr 26
J&J also applied for emergency application... Feb 24
FUJIFILM Diosynth Biotechnologies announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government... Jan 19
Novavax is also currently conducting a Phase 3 clinical study in the United Kingdom, a Phase 2b trial in South Africa and a Phase 1/... Dec 29
COVAX, today announced that it had arrangements in place to access nearly two billion doses of COVID-19 vaccine candidates, on behalf of 190 participating ... Dec 19
COVAX has guaranteed access to a portion of the first wave of production, followed by volume scales as further supply becomes available... Dec 19
Vaccine maker Novavax Inc said on Monday it has pushed back the start of a U.S.-based, late-stage trial for its experimental COVID-... Nov 30
In India, the ICMR has funded the clinical trial site fees while SII is taking care of other expenses for the University of Oxford and ... Nov 13
ICMR is providing continuous support to Serum Institute of India in conducting and funding the ongoing clinical trials of COVISHIELD across 15 centres in India ... Nov 12
Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan ... Oct 29
Serum Institute selects ABEC for large-scale, single-use COVID-19 vaccine manufacturing ... Oct 01
Novavax aims for 2 billion COVID-19 vaccine doses with expanded Serum Institute, India deal ... Sep 16
As part of the expanded agreement, Serum Institute will also manufacture the antigen component of the vaccine dubbed NVX-CoV2373.... Sep 16
Minister of State for Health Ashwini Choubey further informed that discussions on collaborations on the recombinant vaccine developed by Russia are ongoing... Sep 15
It had already been disclosed in July that the British government had reserved 60 million doses of Valneva's inactivated SARS-CoV-2 vaccine under ... Sep 14
Novavax said it expects to finalize an agreement that would see it begin to supply Canada with doses “as early as the second quarter of ... Sep 01
The company plans to produce part of the vaccine at its Czech plant, which will give the country access to the product once it is ... Aug 27
Covid vaccine work advances at steady pace... Aug 26
Novavax vaccine candidate enrolls volunteers for phase 2 trial... Aug 25
-Advertisements-
.jpeg)
Friday, November 22, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)